H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS5619

H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response

Analysis of MDA-MB-231 breast cancer cells treated with DOT1L (disruptor of telomeric silencing 1 like) inhibitor EPZ004777 or DOT1L siRNA. DOT1L is a histone H3-lysine79 (H3K79) methyltransferase. Results provide insight into the role of DOT1L/H3K79 methylation in breast cancer.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 3 agent, 4 dose sets

Platform:: GPL10558
Series:: GSE56630
8 Samples

DataSet

Accession:: GDS5619

ID:: 5619

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 128735229) (1)
GEO DataSets
H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast canc...
H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response
Accession: GDS5619

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets